CAU Y1706 Novel Kazachstania turicensis CAU Y1706 and compositions using the same

摘要

The present invention relates to a novel Kazaztania thuricensis CAU Y1706 and a composition using the same, and more specifically, the Kazaztania thuricensis CAU Y1706 (Accession No.: KCTC13794BP) strain, and the strain or a culture thereof are effective. It relates to a pharmaceutical composition, a food composition, a cosmetic composition, and a probiotic composition for the prevention or treatment of inflammatory diseases including as a component. The novel yeast according to the present invention promotes a Th2 immune response mediated by Treg, has anti-inflammatory activity, has a formal effect, and has an excellent effect of suppressing inflammation in the skin and intestine against the ovalbumin-sensitized mouse model. In addition, it has excellent acid resistance and bile resistance, and thus has high commercial value.